Search

Search Constraints

You searched for: Author/Creator Hamaguchi, Tetsuya

Search Results

11. Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer. Issue 11 (21st October 2019)

13. Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative. (May 2020)

14. Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial. Issue 34 (1st December 2021)

15. Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy. (4th November 2015)

16. Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy. Issue 2 (December 2015)

18. Marked antitumor effect of NK012, a SN-38-incorporating micelle formulation, in a newly developed mouse model of liver metastasis resulting from gastric cancer. (February 2014)

19. O3-7-4Risk Factor Analyses of Severe Cicatricial Stricture after Chemoradiotherapy for Stage II/III (T3) Esophageal Carcinoma. (3rd November 2017)

20. Phase II study of cetuximab with irinotecan for KRAS wild‐type colorectal cancer in Japanese patients. Issue 2 (6th August 2015)